Literature DB >> 6172480

Antigen-specific human T lymphocyte clones: induction, antigen specificity, and MHC restriction of influenza virus-immune clones.

J R Lamb, D D Eckels, P Lake, A H Johnson, R J Hartzman, J N Woody.   

Abstract

Human peripheral blood lymphocytes from an HLA-Dw1,3 individual were primed in vitro with influenza A virus (A/Texas/1-77/x-49) and subsequently cloned by limiting dilution in TCGF. Of the 96 TLCs originally obtained, nine were characterized in detail. TLCs were antigen specific, responding to influenza A virus, not to influenza B, TGAL, GAT, tetanus toxoid, or KLH, and only when antigen was presented by cells unable to form rosettes with AET-treated SRBC. Presentation of antigen by unseparated PBL often resulted in significant "back stimulation," probably via production of growth factors. The MHC requirements for the induction of TLC proliferation were analyzed. Of four representative clones analyzed, three required Dw1;DR1 compatibility for successful presentation of viral antigens by a panel of antigen-presenting cells. In contrast, one TLC showed an unusual pattern of response that could not be correlated to a particular HLA haplotype. Monoclonal anti-T cell antibody analysis of the surface phenotype of two TLCs maintained in continuous culture for 5 mo indicated that they were OKT3+, 4+, and 8-, consistent with an inducer/helper phenotype. To confirm the clonal nature of TLCs, data on the functional properties of TLC subclones are also presented.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6172480

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  Lymphocyte sensitization to Aspergillus fumigatus in allergic bronchopulmonary aspergillosis.

Authors:  C A Walker; P Fitzharris; J L Longbottom; A J Taylor
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

2.  Highly polymorphic products of both HLA-DR and HLA-DQ genes contribute to the polymorphism of the HLA-DRw13 haplotype.

Authors:  J Michon; Y Henin; G Sterkers; C Freidel; L Gebuhrer; H Betuel; J Y Muller; J P Levy
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  Functional definition of HLA-DR and -DQ epitopes specific for DR2-short, DwFJO haplotype.

Authors:  D Zeliszewski; G Sterkers; C Freidel; L Gebuhrer; H Betuel; J P Levy
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  Human T-cell clones to the 70-kilodalton heat shock protein of Mycobacterium leprae define mycobacterium-specific epitopes rather than shared epitopes.

Authors:  E Adams; A Basten; S Rodda; W J Britton
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

5.  T-cell activation by anti-idiotypic antibody: evidence for the internal image.

Authors:  A D Rees; K Praputpittaya; A Scoging; N Dobson; J Ivanyi; D Young; J R Lamb
Journal:  Immunology       Date:  1987-03       Impact factor: 7.397

6.  Human immune responses to herpes simplex virus, varicella-zoster and cytomegalovirus in vitro.

Authors:  S A Williamson; N Parish; J D Chambers; R A Knight
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

7.  Mycobacterial antigen-specific human T-cell clones secreting macrophage activating factors.

Authors:  R Matthews; A Scoging; A D Rees
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

8.  Cloned human T lymphocytes reactive with Dermatophagoides farinae (house dust mite): a comparison of T- and B-cell antigen recognition.

Authors:  R E O'Hehir; D B Young; A B Kay; J R Lamb
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

9.  Human T-cell subset requirements for the production of specific anti-influenza virus antibody in vitro.

Authors:  R Yarchoan; W E Biddison; H S Schneider; D L Nelson
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

10.  CD40-ligand in primate cardiac allograft and viral immunity.

Authors:  R N Pierson; J E Crowe; S Pfeiffer; J Atkinson; A Azimzadeh; G G Miller
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.